Nucleate Michigan X MBVF Venture Series Lecture 2

​​Join Nucleate Michigan and the Michigan Biomedical Venture Fund (MBVF) for the second event in our Venture Capital Lecture Series, exploring how investors evaluate, fund, and build life science startups from concept to clinic.

​This session features David Olson, Mentor-in-Residence at Innovations Partnerships, who has more than 29 years of experience in building companies, product R&D, intellectual property management, business development and venture financing. David will discuss what makes a startup investable, how scientific founders can position their technologies for funding, and lessons learned from supporting Michigan-based biotech and medical technology companies.

​About the Host:​

​​Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.org for more information, and visit https://nucleate.org/privacy-policy/ to read our privacy policy.

​​We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!

​​Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma 

​​Philanthropic Support: Lyda Hill Philanthropies

​​Preferred Partners: Pillar VC, Amino Collective, Excedr, Mercury, Brex, Fedsprout, Browne Consulting

​​In-Kind Support: AcademicLabs, Lens.org, SynBioBeta